Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology

Journal of Addictive Diseases

Volumn 21, Issue 1, 2002, Pages 75-89

  Sim, Tiffanie ^a   Simon, Sara L ^a   Domier, Catherine P ^a   Rawson, Richard A ^a   Ling, Walter ^a   Richardson, Kimberly ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ADHD; Cognition; Methamphetamine

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG DEPENDENCE; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; PREVALENCE; SCORING SYSTEM; SYMPTOMATOLOGY; THINKING; VERBAL BEHAVIOR;

ADULT; AMPHETAMINE-RELATED DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; FEMALE; HUMANS; MALE; METHAMPHETAMINE; PSYCHIATRIC STATUS RATING SCALES;

EID: 0036399196     PISSN: 10550887     EISSN: None     Source Type: Journal    
DOI: 10.1300/J069v21n01_07     Document Type: Article

References (59)

1. Horner BR, Scheibe C, Prevalence and implications of attent ion-deficit hyperactivity disorder among adolescents in treatment for substance abuse. J Am Acad Child Adolesc Psychiatry. 1997;36(1):30-36.
2. Biederman J, Wilens T, Mick E, et al. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): Effects of ADHD and psychiatric comorbidity. Am J Psychiatry. 1995;152:1652-1658.
3. Wilens TE, Biederman J, Spencer TJ, Frances RJ. Comorbidity of attention deficit hyperactivity disorder and psychoactive substance use disorders. Hosp Community Psychiatry. 1994;45:421-435.
4. Tarter RE, Edwards K. Psychological factors associated with the risk for alcoholism. Alcohol Clin Exp Res. 1988;12:471-480.
5. Wilens T, Biederman J, Spencer TJ, Frances RJ. Comorbidity of attention-deficit hyperactivity and psychoactive substance use disorders. Hosp Community Psychiatry. 1994;45:421-435.
6. Weiss G, Hechtman L, Milory T, Perlman T. Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Adolesc Psychiatry. 1985;24:211-220.
7. Mannuzza S, Klein RG, Bessler A, et al. Adult outcome of hyperactive boys: Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry. 1993;50:565-576.
8. Wilens T, Biederman J. The stimulants. Psychiatr Clin North Am 1992;15: 191-222.
9. Findling RL, Dogin JW. Psychopharmacology of ADHD: Children and Adolescents. J Clin Psychiatry. 1998;59(7):42-9.
10. Kempton S, Vance A, Maruff P, et al. Executive function and attention deficit hyperactivity disorder: Stimulant medication and better executive function performance in children. Psychol Med. 1999;29(3):527-38.
11. Chassin L, Rogosch F, Barrera M. Substance use and symptomatology among adolescent children of alcoholics. J Abnorm Psychol. 1991; 100(4):449-63.
12. Khantzian E. The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. Am J Psychiatry. 1985;142:1258-1264.
13. Barkley, RA. Behavioral inhibition, sustained attention, and executive function: Constructing a unified theory of ADHD. Psychol Bull. 1997;121:65-94.
14. Barkley RA, Grodzinsky G, DuPaul GJ. Frontal lobe functions in attention deficit disorder with and without hyperactivity: A review and research report. J Abnorm Child Psychol. 1992;20:163-188.
15. Korkman M, Pesonen AE. A comparison of neuropsychological test profiles of children with attention deficit-hyperactivity disorder and/or learning disorder. J Learn Disabil. 1994;27(6):383-92.
16. Oie M. Rund BR. Neuropsychological deficits in adolescent-onset schizophrenia compared with attention deficit hyperactivity disorder. Am J Psychiatry. 1999; 156(8):1216-22.
17. Faraone SV, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry. 1998;44:951-958.
18. Barkley RA. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York: Guilford Press, 1990.
19. Hynd GW, Riccio CA, Cohen MJ, Gonzalez JJ. Neurological basis of attention deficit hyperactivity disorder. Exceptional Children. 1990;60(2):118-124.
20. Garber SW, Garber MD, Spizman RF, Helping the ADD Hyperactive Child. New York: Villard Books, 1990.
21. Holdnack JA, Moberg PJ, Arnold SE, Gur RC, Speed of processing and verbal learning deficits in adults diagnosed with attention deficit disorder. Neuropsychiatry Neuropsychol Behav Neurol, 1995;8:282-292.
22. Gansler DA, Fucetola R, Krengel M, et al. Are there cognitive subtypes in adult attention deficit/hyperactivity disorder? J Nerv Ment Dis. 1998; 186:776-781.
23. Denckla MB. The child with developmental disabilities grown up: Adult residual of childhood disorders. Neurol Clin. 1993;11:105-125.
24. Aytaclar S, Tarter RE, Kirisci L, Lu S. Association between hyperactivity and executive cognitive functioning in childhood and substance use in early adolescence. J Am Acad Adolesc Psychiatry. 1999;38(2):172-178.
25. Harden PW, Pihl RO. Cognitive function, cardiovascular reactivity, and behavior in boys at high risk for alcoholism. J Abnorm Psychol. 1995; 104:94-103.
26. Tarter RE, Jacob T, Bremer DAJ. Cognitive: Status of sons of alcoholic men. Alcohol Clin Exp Res. 1989;13:232-234.
27. Heischober B, Miller M. Methamphetamine abuse in California. NIDA Res Monogr. 1991;115:60-71.
28. Fleming K, Bigelow LB, Weinberger DR, et al. Neuropsychological effects of amphetamine may correlate with personality characteristics. Psychopharmacol Bull. 1995;31(2):357-361.
29. Carpenter JA. The effect of caffeine and alcohol on simple visual reaction time. J Comp Physiol Psychol. 1959;52:491-496.
30. Mackworth NH. Researches on the Measurement of Human Performance. Medical Research Council, Special Rpt. Series No 268. H.M Stationery Off., 1950, London.
31. Soetens E, Casaer S, D'Hooge R, et al. Effect of amphetamine on long-term retention of verbal material. Psychopharmacology. 1995;119:155-162.
32. Mohs RC, Tinklenberg JR, Roth WT, et al. Methamphetamine and diphenhydramine effects on rate of cognitive processing. Psychopharmacology. 1978;59: 13-19.
33. Simon SL, Domier CP, Carnell J, et al. Cognitive impairment in individuals currently using methamphetamine. Amer J Addict. (In Press).
34. National Attention Deficit Disorder Association. Guiding Principles for the Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder, 1998.
35. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Council report of diagnosis and treatment of attention deficit hyperactivity disorder in children and adolescents. JAMA. 1998;279:1100-1107.
36. Rossini ED, O'Connor MA. Retrospective self-reported symptoms of attention-deficit hyperactivity disorder: Reliability of the Wender Utah Rating Scale, Psychol Rep. 1995;77:751-754.
37. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: An aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150:885-890.
38. Simon SL, Domier CP, Sim T, et al. A comparison of individuals currently using methamphetamine and cocaine. J Addict Diseases. 2002; 21(1):35-44.
39. Simon SL. Treatment for Stimulant Use Disorders. Maryland: U.S. Department of Health and Human Services, 1999.
40. Wechsler D. Manual for the Wechsler Adult Intelligence Scale-Revised. New York: The Psychological Corporation, 1981.
41. Reitan RM. Validity of the trail making test as an indication of organic brain damage. Percept Mot Skills. 1958;8:271-276.
42. Woodcock RW, Johnson MB. Woodcock-Johnson Psycho-Educational Battery. Texas: DLM Teaching Resources, 1977.
43. Golden CJ. Stroop color and word test: A manual for clinical and experimental uses. Illinois: Stoelting Company, 1978.
44. Grant DA, Berg EA. A behavioural analysis of degree of impairment and ease of shifting to new responses in a Weigl-type card sorting problem. J Exp Psychol. 1948;39:404-411.
45. Heaton RK. Wisconsin Card Sorting Test Manual. Florida: Psychological Assessment Resources, 1981.
46. Shipley WC. A self-administering scale for measuring intellectual impairment and deterioration. J Psychol. 1940;9:371-377.
47. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: An aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150(6):885-890.
48. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;3:561-571.
49. Kuperman S, Schlosser SS, Lidral J, Reich W. Relationship of child psychopathology to parental alcoholism and antisocial personality disorder. J Am Acad Child Adoles Psychiatry. 1999;38(6):686-92.
50. Steinhausen HC. Children of alcoholic parents. A review. Eur Child Adolesc Psychiatry. 1995;4(3):143-52.
51. Biederman J, Faroane SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150:1792-1798.
52. Pontius AA, Yudowitz BS. Frontal lobe system dysfunction in some criminal actions in a Narratives Test. J of Nerv Ment Dis. 1980;168:111-117.
53. Eson ME, Yen JK, Bourke RS. Assessment of recovery from serious head injury. J Neurol Neurosurg Psychiatry. 1978;41:1036-1042.
54. Wender PH, Reimherr FW, Wood DR. Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment. Arch Gen Psychiatry. 1981;38:449-456.
55. Wender PH, Reimherr FW, Wood DR, Mattes JA. Stimulant therapy of 'adult hyperactivity.' Arch Gen Psychiatry. 1985;42:840.
56. Corcores JA, Davies RK, Mueller PS, Gold MS. Cocaine abuse and adult attention deficit disorder. J Clin Psychiatry. 1987;48:376-377.
57. Kaminer Y. Desipramine facilitation of cocaine abstinence in an adolescent. J Am Acad Child Adolesc Psychiatry. 1992;31:312-317.
58. Weiss RD, Pope HG, Mirin SM. Treatment of chronic cocaine abuse and attention deficit disorder, residual type, with magnesium pemoline. Drug Alcohol Depend. 1985;142:547-552.
59. Spencer TJ, Wilens T, Biederman J, et al. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry. 1995;52:434-443.